Stock Update: General Electric Company (NYSE:GE) – DILON Diagnostics and GE Healthcare will present GE Healthcare’s FDA 510k pending dual head MBI localization accessory for breast biopsy* at the SBI/ACR Breast Imaging Symposium in April 7-9

[PR Newswire] – NEWPORT NEWS, Va., April 6, 2016 /PRNewswire/ — DILON Diagnostics and GE Healthcare are pleased to announce that they will present GE Healthcare’s FDA 510k pending dual head MBI localization accessory … Read more on this. General Electric Company (GE) , with a current market cap of $286.91B, started trading this morning at $30.89. Today, shares have traded between $30.64 and $31.50 per share and has traded between $19.37 and $32.05 over the past 12 months. Priced at 20.65x this year’s forecasted earnings, GE shares are relatively expensive compared to the industry’s 15.95x forward p/e ratio. And for those looking to make a return holding the stock, the company pays shareholders $0.92 per share annually in dividends, yielding 2.95%. In a review of the consensus earnings estimate this quarter, 14 sell-side analysts are looking at $0.19 per share, which would be $0.01 worse than the year-ago quarter and a $0.08 sequential decrease. What we find to be interesting is that the full-year EPS estimate of $1.50 is a $0.19 better when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $27.86 Billion. If realized, that would be a 5.11% decrease over the year-ago quarter. In terms of ratings, Bernstein downgraded GE from Outperform to Mkt Perform (Apr 4, 2016). Previously, UBS Initiated GE at to Buy. When considering if the stock is under or overvalued, the average price target is $32.92, which is 6.57% above where the stock opened this morning. See more in (NYSE:GE) Similar Articles: Stock Update: General Electric Company (NYSE:GE) – General Electric to move headquarters to Boston – report Market Update: General Electric Company (NYSE:GE) – DILON Diagnostics and GE Healthcare announce a global distribution agreement for the Discovery NM750b Molecular Breast Imaging system Market Update: General Electric Company (NYSE:GE) – Execution on Divestiture Plan Continues – Report on General Electric